{"nct_id":"NCT00712673","title":"GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2008-06","start_date_type":null,"primary_completion_date":"2011-03","primary_completion_date_type":"ACTUAL","completion_date":"2011-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}